- COVID-19 infection increases risk of a range of neurological diseases,
- Cancer patients eating ice cream can reduce this side effect of chemotherapy
- Gut microbes may become a new therapy for depression and anxiety
- The risk of Alzheimer’s disease increases by 50-80% within a year after COVID-19 infection
- Hong Kong will launch monkeypox vaccination for high-risk groups in October
- Ebola (Sudan strain) outbreak in Uganda
Stem cells make organ transplantation possible without risk of rejection!
Stem cells make organ transplantation possible without risk of rejection! The research was published in the journal Stem Cells Translational Medicine.
Our human body has a very powerful and magical protective system, that is, the immune system.
The human immune system can consciously recognize, attack, and eliminate “foreign objects” such as bacteria and viruses from the outside world to achieve the purpose of protecting human health. This is a good thing for healthy people, but it is a big trouble for patients undergoing organ transplantation.
Foreign tissues and organs are recognized by the immune system as a kind of “foreign component” and will attack and destroy the transplant. This immunological reaction is transplant rejection.
Transplantation can save lives, but to prevent the donor’s organs from being rejected by the recipient’s immune system, people must take drugs with serious side effects, which increase the patient’s risk of infection, cardiovascular and metabolic complications, and even malignant tumors, often outweighing the gains.
Transplant rejection seems to have become an unbreakable rule in organ transplantation. After decades of research, scientists have also found a glimmer of light in their continuous exploration.
Injecting mesenchymal stem cells into the body may be a long-term solution to the problem of rejection of organ transplants in the human body.
The first person who benefited from this method was an Italian man who received a kidney transplant. Without anti-rejection drugs, he has fully tolerated the new organ for 18 months. The study was published in Stem Cells Translational Medicine” magazine.
1. The first case in the world! Stem cells resist transplant rejection for up to 18 months
The research was initiated by Giuseppe Remuzzi and his team of the Italian Mario Negri Institute of Pharmacology. As early as 2009, the team designed a clinical study on the safety and feasibility of autologous mesenchymal stem cells in kidney transplant recipients for the first time. However, the trial did not go well, and the patient had kidney transplant dysfunction.
Organ donation without risk of rejection may become a reality. After reflection, researchers have found that the root of the problem lies mainly in the time of stem cell injection.
If the stem cells are injected one day before transplantation, the acute deterioration of graft function can be completely avoided. By modifying the test protocol, it was quickly confirmed in the following experimental patients. Although the safety and clinical feasibility of both autologous and allogeneic mesenchymal stem cells in the treatment of kidney transplantation have been confirmed, there is a lack of immunomodulatory agents in the research after all, and only by understanding the mechanism can we explore the ability to induce long-term transplant tolerance Possibility.
In order to further study, a 37-year-old man who received a kidney transplant from a freight elevator donor became their target. By convention, the day before the transplant, the patient received autologous bone marrow mesenchymal stem cell infusion, and received long-term follow-up attention after the organ transplant.
Renal biopsy at 1 year (D, F) and 8 years (E, G) after transplantation showed that the patient was immune tolerant
The results of the study showed that after stem cell infusion, the patient’s renal function recovered rapidly after transplantation, and the function was stable within 2 years after transplantation. The anti-rejection drugs taken by the patient gradually decreased in about five years until it stopped completely. Taking. As of the time the researchers submitted the paper, the patient had not received immunosuppressive medication for 18 months.
2. The root of transplant rejection is that the immune system does not recognize it
Organ transplantation is usually the last option for patients with advanced organ failure, and it is also the most effective treatment.
If successful, you can live a long time, but you need to rely on immunosuppressive drugs for the rest of your life for a long time. The final cause of death is mostly infections caused by weakened immunity, cardiovascular and malignant tumors caused by drug side effects.
So why does the transplanted organ produce immune rejection reaction to the human body?
The principle is actually very simple. The reason why our human body is healthy mainly depends on the strong immune system to resist the invasion of “foreign enemies”. These “foreign enemies” are common bacteria, viruses, microorganisms, etc. under normal circumstances, and the immune system can quickly eliminate them. Remove obstacles to the body and maintain normal body operation. The transplanted new tissues (organs) are easily considered by the body’s immune system as “foreign enemies” and attack. When the immune system is activated, it will trigger a series of reactions and cause many adverse effects on the body.
Principles of Immune Rejection in Organ Transplantation
Immunosuppressive drugs are used to suppress this strong reaction. If there is no drug suppression, the patient will even be affected quickly and even cause death. Therefore, the problem of organ transplant rejection has always been the biggest problem that plagues clinical medicine, but fortunately, we have a new solution, which is better than immunosuppressive drugs.
3. Stem cells may break the rules of transplant rejection
Since the problem lies in “alien incompatibility”, it seems that the source of the problem has been found. As the basic unit cell that constitutes the human body, stem cells are the original source of all living organisms and are also recognized as the “source of life”. Its magic is not only immune regulation and anti-apoptosis, but also the ability to regenerate new tissues and organs, such as Cardiomyocytes, bone marrow stromal cells, thymic stromal cells, liver cells, nerve cells, pancreatic β cells, vascular endothelial cells, etc.
This is also the fundamental reason why stem cells can play a role in resisting graft rejection.
In fact, as early as more than ten years ago, scientists discovered and recognized the multiple functions of stem cells, especially mesenchymal stem cells. Now they have become a hot research object in the field of stem cells due to their wide range of sources. In 2002, some researchers discovered that mesenchymal stem cells have a strong immunosuppressive ability. Later, they also discovered that mesenchymal stem cells themselves have low immunogenicity. Even if they are used in foreign or cross-species, it is difficult to cause immune rejection. A series of animal experiments and clinical studies have found that mesenchymal stem cells can promote the proliferation of regulatory T lymphocytes, allowing the immune system to restore immune balance.
Immune Regulation of Mesenchymal Stem Cells in Immune Response
The use of these immune properties of mesenchymal stem cells is beneficial for the treatment of immune diseases, including transplant rejection and autoimmune diseases. Mesenchymal stem cells, which have always been high hopes but have been slow to make progress. With more in-depth research by scientists, more application functions and fields of mesenchymal stem cells have been opened up, and mesenchymal stem cells have gradually been developed. It has become an ideal cell for resisting immune rejection, inducing immune tolerance, and long-term maintenance of transplanted organs, and has achieved many exciting results.
(sourceinternet, reference only)